MARKET

CSBR

CSBR

Champions Oncolo
NASDAQ
7.05
-0.02
-0.28%
After Hours: 7.19 +0.14 +1.99% 13:10 12/24 EST
OPEN
7.12
PREV CLOSE
7.07
HIGH
7.26
LOW
7.05
VOLUME
4.27K
TURNOVER
--
52 WEEK HIGH
11.99
52 WEEK LOW
5.59
MARKET CAP
97.90M
P/E (TTM)
42.32
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at CSBR last week (1215-1219)?
Weekly Report · 3d ago
Champions Oncology Reports Strong Growth Amid Strategic Investments
TipRanks · 12/17 00:02
Champions Oncology signals expanding radiolabeling and data platform as margin improves to 52%
Seeking Alpha · 12/15 23:10
Cancer research firm Champions Oncology's Q2 revenue rises as bookings quality improves
Reuters · 12/15 21:12
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga · 12/15 21:06
Champions Oncology Non-GAAP EPS of $0.06, revenue of $15M beats by $0.96M
Seeking Alpha · 12/15 21:02
Champions Oncology Q2 Adj. EPS $0.06 Beats $0.01 Estimate, Sales $15.035M Beat $14.042M Estimate
Benzinga · 12/15 21:01
Top Stocks With Earnings This Week: Micron, FuelCell, Carnival and More
Benzinga · 12/15 15:54
More
About CSBR
Champions Oncology, Inc. is a preclinical and clinical research services provider. The Company is engaged in the development and sale of advanced technology solutions and products to personalize the development and use of oncology drugs through its translational oncology solutions. This technology ranges from computational-based discovery platforms, oncology software solutions, and proprietary experimental tools such as in vivo, ex vivo and biomarker platforms. Utilizing its TumorGraft Technology Platform (the Platform), it provides select services to pharmaceutical and biotechnology companies seeking personalized approaches to drug development. It also sells Lumin Bioinformatics (Lumin), an oncology data-driven software program which contains comprehensive information derived from its research services and clinical studies. Lumin leverages a large data center coupled with analytics and artificial intelligence to provide a robust tool for computational cancer research.

Webull offers Champions Oncology Inc stock information, including NASDAQ: CSBR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CSBR stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CSBR stock methods without spending real money on the virtual paper trading platform.